Company Filing History:
Years Active: 2020
Title: Aránzazu García-Molina: Innovator in Pharmaceutical Science
Introduction
Aránzazu García-Molina is a distinguished inventor based in Toledo, Spain, known for his significant contributions to pharmaceutical science. His innovative work focuses on developing novel compounds that can positively impact various medical conditions.
Latest Patents
García-Molina holds a patent for "Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors." This invention encompasses novel derivatives of 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one, which function as negative allosteric modulators (NAMs) for the mGluR2 receptor subtype. The patent includes details on pharmaceutical compositions containing these compounds, processes for their preparation, and their potential use in treating disorders associated with mGluR2 receptors.
Career Highlights
Aránzazu García-Molina works at Janssen Pharmaceutica NV, a leading pharmaceutical company recognized for its commitment to developing innovative medicines. His expertise in pharmacology and drug development has played a crucial role in advancing these important therapeutic innovations.
Collaborations
Throughout his career, García-Molina has collaborated with various talented professionals, including Sergio-Alvar Alonso-de Diego and José Maria Cid-Núñez. These partnerships have fostered a productive environment for research and have contributed to the success of his inventive endeavors.
Conclusion
Aránzazu García-Molina stands out as an influential inventor in the field of pharmaceutical sciences. His innovative patent work focuses on mGluR2 receptor modulation, highlighting the importance of scientific research in developing new treatments for various disorders. As he continues to collaborate with other researchers, his contributions will undoubtedly shape the future of pharmaceuticals and improve patient outcomes.